Danaher and Lujiang Innovation Laboratory Launch AI-Native Marine Biomanufacturing Initiative
On June 8, Danaher and Lujiang Innovation Laboratory signed a cooperation agreement to establish what is described as the first AI-native closed-loop marine biomanufacturing system. The partnership aims to integrate AI agents, automation, and high-throughput technologies into the full R&D workflow—from microbial discovery and genomic analysis to product validation—significantly accelerating the development of marine biotechnology applications.
The collaboration will focus on areas including deep-sea microbial biomanufacturing, biomimetic materials, and marine-inspired synthetic biology. By combining Danaher’s technology platforms and operational expertise with Lujiang’s marine research capabilities, the initiative seeks to advance the commercialization of marine bioresources and strengthen innovation in the emerging blue bioeconomy.
KingMed Diagnostics and United Family Healthcare Partner on Precision Healthcare Services
On June 8, KingMed Diagnostics and United Family Healthcare signed a strategic partnership to combine high-end clinical care with precision diagnostics. The collaboration will focus on three key areas—oncology, personalized health management, and brain health—creating an integrated care model that spans early detection, diagnosis, treatment, and long-term follow-up.
By combining United Family’s premium clinical network with KingMed’s nationwide laboratory infrastructure and AI-enabled diagnostic capabilities, the partnership aims to accelerate the adoption of precision medicine and deliver more personalized, lifecycle-based healthcare services to patients across China.
QuiCheck and Leli Holding Group Partner on Functional Medicine and Preventive Health
QuiCheck Health, a consumer health brand under DIAN Diagnostics, has entered a strategic partnership with Leli Holding Group to jointly develop a functional medicine ecosystem that integrates precision testing with personalized nutritional intervention. The collaboration aims to create a closed-loop health management model spanning home-based testing, health assessments, targeted supplementation, and ongoing wellness services.
By combining DIAN’s diagnostic expertise with Leli’s health management and service network, the partnership reflects growing momentum in proactive healthcare, where data-driven screening and individualized interventions are increasingly shaping the future of preventive medicine.
Medcaptain Medical Technology Joins National Project on Emerging Infectious Disease Surveillance
Medcaptain Medical Technology has joined a national major science and technology project led by the Institute of Microbiology Chinese Academy of Sciences to strengthen surveillance and early-warning systems for high-risk pathogens across Central Asia. The initiative aims to establish an integrated “One Health” framework covering humans, animals, vectors, and the environment to improve cross-border infectious disease preparedness.
As a project participant, Medcaptain Medical Technology will contribute to the development of automated droplet digital PCR and chemiluminescence immunoassay technologies, supporting high-throughput pathogen detection and localized deployment of diagnostic solutions. The collaboration highlights growing efforts to combine advanced diagnostics, AI, and data-driven surveillance to enhance regional public health resilience.
